The Addition of Thalidomide to the Induction Treatment of Newly Presenting Myeloma Patients Increases the CR Rate Which Is Likely to Translate Into Improved PFS and OS.
暂无分享,去创建一个
G. Morgan | W. Gregory | M. Drayson | F. Ross | F. Davies | G. Jackson | S. Bell | K. Cocks | A. Szubert | J. Child | R. Owen | N. N. Coy